Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker

por Qiu, Yingqi, Wang, Hao, Liao, Peiyun, Xu, Binyan, Hu, Rong, Yang, Yulu, Li, Yuhua
Publicado 2022

Next frontier in tumor immunotherapy: macrophage-mediated immune evasion

por Qiu, Yingqi, Chen, Tong, Hu, Rong, Zhu, Ruiyi, Li, Chujun, Ruan, Yingchen, Xie, Xiaoling, Li, Yuhua
Publicado 2021

Enhanced tumor immunotherapy by polyfunctional CD19-CAR T cells engineered to secrete anti-CD47 single-chain variable fragment

por Qiu, Yingqi, Liao, Peiyun, Wang, Hao, Chen, Jianyu, Hu, Yuxing, Hu, Rong, Zhang, Honghao, Li, Zhongwei, Cao, Manxiong, Yang, Yulu, Li, Meifang, Xie, Xiaoling, Li, Yuhua
Publicado 2023

Histone acetylation by HBO1 (KAT7) activates Wnt/β-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia

por Wang, Hao, Qiu, Yingqi, Zhang, Honghao, Chang, Ning, Hu, Yuxing, Chen, Jianyu, Hu, Rong, Liao, Peiyun, Li, Zhongwei, Yang, Yulu, Cen, Qingyan, Ding, Xiangyang, Li, Meifang, Xie, Xiaoling, Li, Yuhua
Publicado 2023

TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice

por Xie, Xiaoling, Zhang, Wuju, Xiao, Min, Wei, Tiantian, Qiu, Yingqi, Qiu, Jingyang, Wang, Hao, Qiu, Zeyou, Zhang, Sheng, Pan, Yating, Mao, Linlin, Li, Yuhua, Guo, Bin, Yang, Wanwen, Hu, Yuxing, Hu, Shujie, Gong, Yan, Yang, Jun, Xiao, Guozhi, Zhang, Yue, Bai, Xiaochun
Publicado 2023